MMC

MMC (Marsh & McLennan Companies, Inc.) Analyst Note Date: 2026-06-13 Current Price: $182.70

1. Structural Readiness

State: Forming. Conservative Entry: Not yet actionable. A conservative entry requires a confirmed breakout above the coil resistance. Aggressive/Pre-Breakout Entry: Not recommended as a standalone signal; the setup is incomplete. Breakout Level: Not yet established; requires price to close decisively above the coil resistance. Current Price: $182.70. Extension: Not applicable (price has not yet broken out to extend). ATR Context: Current ATR is 1.6% (sub-threshold). This indicates low volatility relative to the historical "sweet spot" (4–6%). While this suggests a tight range, it also implies a lack of immediate momentum required to trigger a confirmed breakout.

2. Thesis Layer

This is a TACTICAL, setup-led name. As of 2026-06-13, there is NO named macro or secular thesis attached to this specific setup in the evidence base. The investment case must be judged strictly on the quality of the structural setup (the forming coil) and the underlying business fundamentals provided in the earnings transcripts and company profiles. No external thematic drivers (e.g., specific regulatory shifts or geopolitical events) are cited in the evidence to weight conviction beyond the operational performance.

3. Business Overview

Company: Marsh & McLennan Companies, Inc. (MMC). Industry: Professional Services / Insurance Brokerage & Consulting. Business Model: MMC operates as a leading global professional services organization bifurcated into two primary divisions: Risk and Insurance Services and Consulting.

• Risk and Insurance Services: Provides risk management capabilities, strategic risk advice, risk transfer mechanisms, and insurance/reinsurance brokerage. The segment also offers catastrophe and financial modeling and manages insurance programs.
• Consulting: Specializes in advisory services related to health, wealth, and career development, alongside management, economic analysis, and brand strategy consulting.

Key Operational Metrics (as of Q1 2026):

• Assets Under Management (AUM): $727 billion at the end of Q1 2026, representing a 5% sequential increase and a 19% year-over-year increase.
• Advised Assets: The firm advises on approximately $17 trillion in assets globally.
• Segment Performance: Mercer (Consulting division) reported revenue of $1.7 billion for the quarter, up 11% (or 5% on an underlying basis). Health growth within Mercer was 6%, driven by international expansion.
• Client Base: Diverse, including businesses, governmental bodies, insurance companies, associations, and private individuals.

4. Archetype and Conviction

Archetype: Quality Compounder. Rationale: The evidence supports a "Quality Compounder" classification due to the consistent growth in AUM (19% YoY), the scale of advised assets ($17T), and the margin expansion guidance. The company demonstrates the ability to reinvest savings for growth while managing a significant transformation charge ($500M) to achieve long-term efficiency ($400M savings).

Valuation & Fundamentals:

• Forward Consensus: FY1 EPS consensus is $10.31; FY2 EPS consensus is $11.23.
• Management Expectations: Management expects to generate more margin expansion in the second half of 2026 than in the first half. This is a forward-looking statement recorded by management on 2026-04-16, indicating an expectation of operational leverage improving in H2.
• Transformation: The company is executing a $500M charge program to generate $400M in total savings, a portion of which will be reinvested for growth.

Conviction Stack:

• Thesis Strength: Low (No named macro thesis; purely tactical).
• Evidence Quality: High (Strong earnings data, clear AUM growth, specific margin guidance).
• Structural Quality: Moderate (ATR is sub-threshold at 1.6%, suggesting a lack of volatility; setup is forming, not confirmed).
• Setup Readiness: Partial (Forming coil requires a breakout to become actionable).
• Rerating Potential: Dependent on the successful execution of the margin expansion guidance in H2 2026 and a confirmed technical breakout.

5. Invalidations, Strengths, and Gaps

What Would Strengthen the Case:

• A confirmed price breakout above the coil resistance (triggering the "Confirmed" state).
• Further evidence of margin expansion exceeding the H2 guidance provided by management.
• Continued sequential growth in AUM beyond the 5% Q1 rate.

What Would Invalidate the Case:

• A significant miss on the $400M savings target or a delay in the reinvestment of savings.
• A contraction in AUM or advised assets.

Gaps in Evidence:

• Volatility Context: The current ATR of 1.6% is sub-threshold. There is no historical comparison of MMC's ATR at previous breakout points to determine if the current low volatility is typical or anomalous.
• Macro Context: No specific macroeconomic data points (e.g., interest rate environment, M&A volume) are provided to contextualize the $17T advised assets or the 19% AUM growth.

PRIVATE ANALYST CALL

Judgment: Hold Confidence: medium Key evidence: AUM grew 19% YoY to $727B; Management expects H2 margin expansion to exceed H1; Forward EPS consensus shows growth trajectory. Key risks: Technical setup is forming but not confirmed (sub-threshold ATR); $500M transformation charge may impact near-term earnings; No named macro thesis to support immediate rerating. Sizing hint: Position size should be minimal or zero until a confirmed breakout occurs; do not size based on the forming coil alone. Expected path: Price likely consolidates within the forming coil range while management executes the margin expansion plan in H2 2026; a breakout is required to shift the setup to "Confirmed." Expected horizon: 3 to 6 months, contingent on the completion of the H2 margin expansion and a technical breakout.